Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019

ResearchMoz include new market research report" Gastrointestinal Therapeutics in Asia-PacificMarkets to 2019: Industry Size, Shares, Growth, Trends And Forecast" to its huge collection of research reports.

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 – Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need", which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the therapeutic indications of gastrointestinal disorders, namely Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three gastrointestinal indications.

View Full Report With Complete TOC at http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacific-markets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-need-report.html

 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Gastrointestinal Therapeutics in Asia-Pacific Market – Introduction
2.1 Irritable Bowel Syndrome
2.1.1 Classification
2.1.2 Symptoms
2.1.3 Etiology
2.1.4 Pathophysiology
2.1.5 Diagnosis
2.1.6 Epidemiology
2.1.7 Prognosis
2.1.8 Treatment Options
2.2 Ulcerative Colitis
2.2.1 Classification
2.2.2 Symptoms
2.2.3 Etiology
2.2.4 Pathophysiology
2.2.5 Diagnosis
2.2.6 Epidemiology
2.2.7 Prognosis
2.2.8 Treatment Options
2.3 Crohn’s Disease
2.3.1 Classification
2.3.2 Symptoms
2.3.3 Etiology
2.3.4 Pathophysiology
2.3.5 Diagnosis
2.3.6 Epidemiology
2.3.7 Prognosis
2.3.8 Treatment Options
2.4 GBI Research Report Guidance

3 Gastrointestinal Therapeutics in Asia-Pacific Market – Marketed Products (Global)
3.1 Irritable Bowel Syndrome
3.2 Ulcerative Colitis
3.3 Crohn’s Disease
3.4 Key Marketed Products
3.4.1 Amitiza
3.4.2 Humira
3.4.3 Remicade
3.4.4 Simponi
3.4.5 Cimzia
3.4.6 Tysabri

4 Gastrointestinal Therapeutics in Asia-Pacific Market – Pipeline Analysis
4.1 Irritable Bowel Syndrome
4.1.1 Overall Pipeline
4.1.2 Pipeline Analysis by Molecule Type
4.1.3 Pipeline Analysis by Mechanism of Action
4.2 Ulcerative Colitis Pipeline
4.2.1 Overall Pipeline
4.2.2 Pipeline Analysis by Molecule Type
4.2.3 Pipeline Analysis by Mechanism of Action
4.2.4 Crohn’s Disease Pipeline
4.2.5 Overall Pipeline
4.2.6 Pipeline Analysis by Molecule Type
4.2.7 Pipeline Analysis by Mechanism of Action
4.3 Promising Drug Candidates in the Pipeline
4.3.1 GSK-1605786
4.3.2 MLN0002
4.3.3 EMD-61753

5 Gastrointestinal Therapeutics in Asia-Pacific Market – Market Forecast to 2019
5.1 Asia-Pacific Markets
5.1.1 Treatment Usage Patterns
5.1.2 Annual Cost of Therapy
5.1.3 Market Size
5.2 Australia
5.2.1 Treatment Usage Patterns
5.2.2 Annual Cost of Therapy
5.2.3 Market Size
5.3 India
5.3.1 Treatment Usage Patterns
5.3.2 Annual Cost of Therapy
5.3.3 Market Size
5.4 China
5.4.1 Treatment Usage Patterns
5.4.2 Annual Cost of Therapy
5.4.3 Market Size
5.5 Japan
5.5.1 Treatment Usage Patterns
5.5.2 Annual Cost of Therapy
5.5.3 Market Size
5.6 Drivers and Barriers
5.6.1 Drivers
5.6.2 Barriers

6 Gastrointestinal Therapeutics in Asia-Pacific Market – Deals and Strategic Consolidations (Global)
6.1 Deals Analysis
6.2 Major Co-Development Deals
6.2.1 AstraZeneca Enters into Co-Development Agreement with Ironwood Pharma for Linaclotide
6.2.2 Amgen Enters into Co-development Agreement with AstraZeneca for Five Monoclonal Antibodies
6.2.3 Galapagos and AbbVie Extend GLPG0634 Development Agreement to Include Crohn's Disease
6.3 Major Licensing Deals
6.3.1 AstraZeneca Enters into Licensing Agreement with Ardelyx for NHE3 Inhibitor Program
6.3.2 Sanofi-Aventis Enters into Licensing Agreement with Kyowa Hakko Kirin
6.3.3 GlaxoSmithKline Enters into Licensing Agreement with ChemoCentryx

7 Gastrointestinal Therapeutics in Asia-Pacific Market – Appendix
7.1 Market Definitions
7.2 Abbreviations
7.3 Sources
7.4 All Pipeline Drugs by Phase
7.4.1 Discovery
7.4.2 Preclinical
7.4.3 IND/CTA-filed
7.4.4 Phase I
7.4.5 Phase II
7.4.6 Phase III
7.4.7 Pre-Registration
7.4.8 Undisclosed
7.5 Market Forecasts to 2019
7.5.1 Asia-Pacific Markets
7.5.2 Australia
7.5.3 India
7.5.4 China
7.5.5 Japan
7.6 Research Methodology
7.6.1 Coverage
7.6.2 Secondary Research
7.6.3 Primary Research
7.6.4 Therapeutic Landscape
7.6.5 Geographical Landscape
7.6.6 Pipeline Analysis
7.7 Expert Panel Validation
7.8 Contact Us
7.9 Disclaimer


List of Tables
Table 1: Gastrointestinal Therapeutics Market, Irritable Bowel Syndrome, Classification, 2009
Table 2: Gastrointestinal Therapeutics Market, Treatment Recommendations for Irritable Bowel Syndrome, 2009
Table 3: Gastrointestinal Therapeutics Market, Classification of Ulcerative Colitis, 2004
Table 4: Gastrointestinal Therapeutics Market, Diagnosis of Ulcerative Colitis, 2007
Table 5: Gastrointestinal Therapeutics Market, Difference Between Ulcerative Colitis and Crohn’s Disease, 2007
Table 6: Gastrointestinal Therapeutics Market, Treatment Options of Ulcerative Colitis, 2011
Table 7: Gastrointestinal Therapeutics Market, Classification of Crohn’s Disease, 2013
Table 8: Gastrointestinal Therapeutics Market, Percentage of Patients Affected by Symptoms of Crohn’s Disease (%), 2012
Table 9: Gastrointestinal Therapeutics Market, Treatment Options for Crohn’s Disease, 2009
Table 10: Gastrointestinal Therapeutics Market, Global, Pipeline (Discovery), 2013
Table 11: Gastrointestinal Therapeutics Market, Global, Pipeline (Preclinical), 2013
Table 12: Gastrointestinal Therapeutics Market, Global, Pipeline (IND/CTA-filed), 2013
Table 13: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase I), 2013
Table 14: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase II), 2013
Table 15: Gastrointestinal Therapeutics Market, Global, Pipeline (Phase III), 2013
Table 16: Gastrointestinal Therapeutics Market, Global, Pipeline (Pre-Registration), 2013
Table 17: Gastrointestinal Therapeutics Market, Global, Pipeline (Undisclosed), 2012
Table 18: Gastrointestinal Therapeutics Asia-Pacific Markets, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 19: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Ulcerative Colitis, Market Forecast, 2012–2019
Table 20: Gastrointestinal Therapeutics Market, Asia-Pacific Markets, Crohn’s Disease, Market Forecast, 2012–2019
Table 21: Gastrointestinal Therapeutics Market, Australia, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 22: Gastrointestinal Therapeutics Market, Australia, Ulcerative Colitis, Market Forecast, 2012–2019
Table 23: Gastrointestinal Therapeutics Market, Australia, Crohn’s Disease, Market Forecast, 2012–2019
Table 24: Gastrointestinal Therapeutics Market, India, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 25: Gastrointestinal Therapeutics Market, India, Ulcerative Colitis, Market Forecast, 2012–2019
Table 26: Gastrointestinal Therapeutics Market, India, Crohn’s Disease, Market Forecast, 2012–2019
Table 27: Gastrointestinal Therapeutics Market, China, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 28: Gastrointestinal Therapeutics Market, China, Ulcerative Colitis, Market Forecast, 2012–2019
Table 29: Gastrointestinal Therapeutics Market, China, Crohn’s Disease, Market Forecast, 2012–2019
Table 30: Gastrointestinal Therapeutics Market, Japan, Irritable Bowel Syndrome, Market Forecast, 2012–2019
Table 31: Gastrointestinal Therapeutics Market, Japan, Ulcerative Colitis, Market Forecast, 2012–2019
Table 32: Gastrointestinal Therapeutics Market, Japan, Crohn’s Disease, Market Forecast, 2012–2019


List of Figures
Figure 1: Gastrointestinal Therapeutics Market, Treatment Algorithm of Ulcerative Colitis, 2007
Figure 2: Gastrointestinal Therapeutics Market, Global, Sales of Amitiza ($m), 2006–2012
Figure 3: Gastrointestinal Therapeutics Market, Global, Sales of Humira ($bn), 2006–2012
Figure 4: Gastrointestinal Therapeutics Market, Global, Sales of Remicade ($bn), 2006–2012
Figure 5: Gastrointestinal Therapeutics Market, Global, Sales of Simponi ($m), 2009–2012
Figure 6: Gastrointestinal Therapeutics Market, Global, Sales of Cimzia ($m), 2008–2012
Figure 7: Gastrointestinal Therapeutics Market, Global, Sales of Tysabri ($m), 2006–2012
Figure 8: Gastrointestinal Therapeutics Market, Global, Irritable Bowel Syndrome, Pipeline, (%), 2013
Figure 9: Gastrointestinal Therapeutics Market, Global, Irritable Bowel Syndrome, Pipeline by Molecule Type, 2013
Figure 10: Gastrointestinal Therapeutics Market, Global, Irritable Bowel Syndrome, Pipeline by Mechanism of Action, 2012
Figure 11: Gastrointestinal Therapeutics Market, Global, Ulcerative Colitis, Pipeline, (%) 2013
Figure 12: Gastrointestinal Therapeutics Market, Global, Ulcerative Colitis, Pipeline by Molecule Type, 2013
Figure 13: Gastrointestinal Therapeutics Market, Global, Ulcerative Colitis, Pipeline by Mechanism of Action, 2013
Figure 14: Gastrointestinal Therapeutics Market, Global, Crohn’s Disease, Pipeline, (%), 2013
Figure 15: Gastrointestinal Therapeutics Market, Global, Crohn’s Disease, Pipeline by Molecule Type, 2013
Figure 16: Gastrointestinal Therapeutics Market, Global, Crohn’s Disease, Pipeline by Mechanism of Action, 2013
Figure 17: Gastrointestinal Therapeutics Market, Asia-Pacific, Market Size, 2012–2019
Figure 18: Gastrointestinal Therapeutics Market, Australia, Market Size, 2012–2019
Figure 19:  Gastrointestinal Therapeutics Market, India, Market Size, 2012–2019
Figure 20: Gastrointestinal Therapeutics Market, China, Market Size, 2012–2019
Figure 21: Gastrointestinal Therapeutics Market, Japan, Market Size, 2012–2019
Figure 22: Gastrointestinal Therapeutics Market, Global, Deals, 2006–2013
Figure 23: Gastrointestinal Therapeutics Market, Global, Co-Development Deals, 2006–2013
Figure 24: Gastrointestinal Therapeutics Market, Global, Licensing Deals, 2006–2013
Figure 25: GBI Research Market Forecasting Model

View Full Report - http://www.researchmoz.us/gastrointestinal-therapeutics-in-asia-pacific-markets-to-2019-strong-potential-for-pipeline-biologics-on-account-of-high-regional-unmet-need-report.html

About ResearchMoz 

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Website@ http://www.researchmoz.us/
Email: sales@researchmoz.us

Browse Blog - http://pramoddige91.wordpress.com/